ISSN: XXXX-XXXX
Abhi International Journal of
Biological Science ( AIJBS )
Login/Register
For Reference
About Journal Aim and Scope Editorial Board Publication Ethics Indexing And Abstracting Peer Review Process About Journal Aim and Scope Editorial Board Publication Ethics Indexing And Abstracting Peer Review Process

Investigating the Role of Gut Microbiome Metabolites in Diabetic Chronic Kidney Disease

Authors: Sanat Sharma

Published: 2025-02-21 19:13:59.506

Download PDF

Abstract

Gut microbiome metabolites play a very complex role in the progression of Diabetic Chronic Kidney Disease, with the necessity to understand the mechanistic pathways connecting these metabolites with kidney health. This article discusses the five critical points: the role of gut microbiota in the formation of DCKD-related metabolites, host genes being targeted, mechanistic pathways involved, microbial species and DCKD, and therapeutic potential of such an interaction. Utilizing computational models and enrichment analyses, findings confirm the significant role of specific metabolites such as 3-Indole propionic acid and microbial species like F. prausnitzii in mitigating DCKD progression. These metabolites modulate disease pathways, particularly the MAPK/NF-KB1 signaling, showcasing potential therapeutic applications. This research bridges gaps in understanding the gut-kidney axis and emphasizes the need for experimental validation to advance microbiome-targeted interventions for DCKD management.

Keywords

Microbiota

References

  1. Jandhyala, S. M., Talukdar, R., Subramanyam, C., et al. (2015). Role of the normal gut microbiota. World Journal of Gastroenterology, 21(29), 8787-8803.
  2. Kim, D. H. (2015). Gut microbiota-mediated drug-antibiotic interactions. Drug Metabolism and Disposition, 43(10), 1581-1589.
  3. Xu, X., Gao, J., Han, J., et al. (2019). The role of gut microbiota in kidney disease development and progression. Frontiers in Physiology, 10, 492.
  4. Nicholson, J. K., Holmes, E., Kinross, J., et al. (2012). Host-gut microbiota metabolic interactions. Science, 336(6086), 1262-1267.
  5. Kobayashi, M., Mikami, D., Kimura, H., et al. (2020). Gut microbiota as a potential therapeutic target in chronic kidney disease. Nephrology Dialysis Transplantation, 35(6), 943-950.
  6. Wang, Z., Klipfell, E., Bennett, B. J., et al. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472(7341), 57-63.
  7. Vaziri, N. D., Wong, J., Pahl, M., et al. (2013). Chronic kidney disease alters intestinal microbial flora. Kidney International, 83(2), 308-315.
  8. Holmes, E., Kinross, J., Gibson, G. R., et al. (2012). Therapeutic modulation of microbiota-host metabolic interactions. Science Translational Medicine, 4(137), 137rv6.
  9. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy
  10. Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014 Hyperglycemia modulates redox, inflammatory and vasoactive markers through specific signaling pathways in cerebral endothelial cells: Insights on insulin protective action
  11. L., Craig, P.A., Crichlow, G. V., Dalenberg, K., Duarte, J.M., Dutta, S., Fayazi, M., Feng, Z., Flatt, J.W., Ganesan, S., Ghosh, S., Goodsell, D.S., Green, R.K., Guranovic, V., Henry, J., Hudson, B.P., Khokhriakov, I., Lawson, C.L., Liang, Y., Lowe, R., Peisach, E., Persikova, I., Piehl, D.W., Rose, Y., Sali, A., Segura, J., Sekharan, M., Shao, C., Vallat, B., Voigt, M., Webb, B., Westbrook, J.D., Whetstone, S., Young, J.Y., Zalevsky, A., Zardecki, C., 2023. RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning. Nucleic Acids Res. https://doi.org/10.1093/nar/gkac1077.
  12. GutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites
  13. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function
  14. Kassie, T.D., Anagaw, T.F., Mazengia, E.M., Gelaw, S.S., 2023. Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis. Diabetol. Metab. Syndr. https://doi.org/10.1186/s13098-023-01202-x.
Download PDF

How to Cite

Sanat Sharma, (2025-02-21 19:13:59.506). Investigating the Role of Gut Microbiome Metabolites in Diabetic Chronic Kidney Disease. Abhi International Journal of Biological Science, Volume kFWVT1s8G5AKKSB60r9I, Issue 1.

Follow Us
Get In Touch

Vitthal Namdev Nagar, Opp Jain Temple Sanganer Sanganer Bazar Jaipur 302029 Rajasthan (India)

mail@abhijournals.com

© Abhi International Journals. All Rights Reserved.